Differential HFE gene expression is regulated by alternative splicing in human tissues

Area of Science:

• Molecular Biology
• Genetics
• Human Physiology

Background:

• The exact pathophysiology of HFE-related Hereditary Hemochromatosis and the precise function of HFE protein in iron regulation are not fully understood.
• The role of alternative splicing in regulating HFE gene expression and the functions of its resulting protein isoforms remain largely unknown.

Purpose of the Study:

• To investigate the physiological significance of alternative splicing variants of the HFE gene.
• To elucidate the function and characteristics of different HFE protein isoforms.

Main Methods:

• Identification and quantification of alternatively spliced HFE transcripts using RT-PCR and real-time PCR.
• Analysis of protein localization, trafficking, and interactions using immunoprecipitation and immunofluorescence assays in transfected cells.

Main Results:

• Tissue-specific alternative splicing of HFE transcripts was observed, with exon 2 skipping and intron 4 inclusion variants showing distinct distribution.
• The exon 2 skipping variant produced a misfolded protein retained in the ER and unable to bind key partners.
• The intron 4 inclusion variant yielded a soluble HFE (sHFE) protein secreted in association with beta-2-microglobulin (β2M).

Conclusions:

• Alternative splicing represents a significant post-transcriptional regulatory mechanism for the HFE gene, exhibiting tissue-specific patterns.
• A secreted sHFE isoform was identified, potentially influencing iron homeostasis by acting as an agonist or antagonist to full-length HFE.
• This sHFE isoform may regulate hepcidin expression in the liver or dietary iron absorption in the duodenum, offering new insights into iron metabolism.